Brazil’s Hypera Unanimously Rejects EMS’ Proposed Merger
The Move Would Have Created The Largest Local Generics Player
Only days after its initial announcement, Hypera Pharma has refused EMS’ proposed merger on grounds of undervaluation and different strategic priorities.
